Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
VOR	VOR BIOPHARMA INC	$84.77M	-119.70%	-82.40%	-94.07%	-124.60%	0.48	5.19	N/A	N/A	N/A
ELTX	ELICIO THERAPEUTICS INC	$78.49M	N/A	-194.40%	-308.87%	-272.80%	-3.49	1.80	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$7.51B	-33.50%	-29.90%	-25.09%	-37.80%	0.13	14.20	N/A	N/A	N/A
APGE	APOGEE THERAPEUTICS INC	$2.34B	-24.10%	-23.10%	-25.11%	-36.00%	0.05	18.55	N/A	N/A	N/A
CDTX	CIDARA THERAPEUTICS INC	$228.76M	-173.30%	-112.60%	-102.77%	705.80%	0.32	4.25	100.00%	-13,319.80%	-13,319.76%
KPTI	KARYOPHARM THERAPEUTICS INC	$56.81M	N/A	-39.60%	-53.97%	-15.50%	-1.88	1.70	95.90%	-52.60%	-26.81%
VYGR	VOYAGER THERAPEUTICS INC	$196.54M	-19.90%	-15.10%	-18.74%	-22.30%	0.31	5.56	100.00%	-81.30%	-80.42%
TNGX	TANGO THERAPEUTICS INC	$152.43M	-55.40%	-35.80%	-46.74%	-43.00%	0.59	6.98	100.00%	-309.70%	-309.24%
XFOR	X4 PHARMACEUTICALS INC	$24.95M	-84.50%	-23.10%	-24.98%	-31.10%	5.61	3.41	68.80%	-1,464.60%	-1,109.58%
ANNX	ANNEXON INC	$204.06M	-44.30%	-38.40%	-43.25%	-53.40%	0.19	10.37	N/A	N/A	N/A
DTIL	PRECISION BIOSCIENCES INC	$59.12M	12.30%	4.50%	7.37%	27.30%	1.42	6.34	100.00%	10.40%	13.03%
SLDB	SOLID BIOSCIENCES INC	$256.50M	-70.40%	-56.70%	-78.51%	-92.40%	0.38	5.20	N/A	N/A	N/A
CRVO	CERVOMED INC	$78.85M	-46.50%	-42.50%	-41.56%	-60.90%	0.10	11.11	100.00%	-167.30%	-167.29%
COGT	COGENT BIOSCIENCES INC	$593.16M	-74.90%	-63.30%	-94.00%	-101.80%	0.28	5.32	N/A	N/A	N/A
MRNA	MODERNA INC	$11.01B	-30.10%	-22.80%	-30.22%	-29.10%	0.30	3.67	54.80%	-110.00%	-111.46%
RAPT	RAPT THERAPEUTICS INC	$122.37M	-98.90%	-82.20%	-67.65%	-193.30%	0.27	4.87	N/A	N/A	N/A
ALMS	ALUMIS INC	$225.25M	N/A	-98.40%	-101.43%	-222.30%	0.31	6.01	N/A	N/A	N/A
CTNM	CONTINEUM THERAPEUTICS INC	$106.33M	-30.70%	-21.80%	-20.83%	-28.20%	0.08	20.69	N/A	N/A	N/A
DYN	DYNE THERAPEUTICS INC	$1.33B	-49.00%	-45.20%	-48.91%	-138.60%	0.10	15.60	N/A	N/A	N/A
PLRX	PLIANT THERAPEUTICS INC	$97.37M	-56.80%	-45.50%	-56.99%	-51.90%	0.31	10.91	N/A	N/A	N/A
BHVN	BIOHAVEN LTD	$2.26B	-237.70%	-159.20%	-183.49%	-336.80%	0.45	3.49	N/A	N/A	N/A
PHVS	PHARVARIS NV	$1.00B	-42.70%	-40.20%	N/A	-1,555.60%	0.09	N/A	N/A	N/A	N/A
IMUX	IMMUNIC INC	$89.25M	-194.40%	-135.70%	-537.67%	641.20%	1.22	1.77	N/A	N/A	N/A
BCTX	BRIACELL THERAPEUTICS CORP	$16.54M	N/A	-147.90%	27.34%	-75.60%	1.90	1.37	N/A	N/A	N/A
ATAI	ATAI LIFE SCIENCES NV	$297.46M	-91.50%	-70.90%	-108.97%	-76.70%	0.37	3.21	100.00%	-48,464.00%	-47,565.26%
GUTS	FRACTYL HEALTH INC	$62.13M	-120.60%	-51.70%	-77.79%	-78.00%	2.80	3.63	46.20%	-75,732.30%	-73,864.52%
CBUS	CIBUS INC	$73.85M	-134.30%	-55.70%	-65.77%	-88.60%	2.74	0.85	100.00%	-5,898.40%	-5,095.47%
CHRS	COHERUS BIOSCIENCES INC	$119.37M	-29.50%	4.80%	33.62%	18.10%	-4.40	1.21	56.00%	10.70%	20.85%
INBX	INHIBRX BIOSCIENCES INC	$178.49M	1,243.20%	710.30%	1,214.73%	4,559.00%	0.35	3.94	100.00%	843,786.00%	850,532.50%
CLNN	CLENE INC	$25.50M	N/A	-109.20%	-207.30%	-149.90%	-4.09	1.57	79.50%	-11,520.50%	-10,332.16%
BMEA	BIOMEA FUSION INC	$78.90M	-151.00%	-111.90%	-237.58%	-1,895.30%	0.55	3.15	N/A	N/A	N/A
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$113.79M	-135.20%	-79.60%	-101.76%	-138.90%	1.31	4.27	92.30%	-2,313.30%	-2,313.27%
CDXS	CODEXIS INC	$190.53M	-92.90%	-45.10%	-43.75%	-44.00%	1.23	4.18	72.60%	-110.00%	-92.42%
KYTX	KYVERNA THERAPEUTICS INC	$99.83M	-40.30%	-36.50%	-47.01%	-66.50%	0.14	8.61	N/A	N/A	N/A
ADVM	ADVERUM BIOTECHNOLOGIES INC	$68.10M	-92.70%	-56.00%	-83.42%	-77.10%	1.54	5.73	100.00%	-13,092.70%	-13,092.70%
ALDX	ALDEYRA THERAPEUTICS INC	$158.23M	-60.70%	-45.70%	-62.70%	-126.70%	0.47	5.60	N/A	N/A	N/A
RANI	RANI THERAPEUTICS HOLDINGS INC	$63.80M	-782.50%	-67.70%	-149.23%	-45.00%	16.64	1.50	100.00%	-2,920.00%	-2,430.45%
GALT	GALECTIN THERAPEUTICS INC	$86.56M	N/A	-188.80%	231.70%	-54.00%	-1.15	0.49	N/A	N/A	N/A
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$513.76M	-38.20%	-11.20%	-10.41%	-12.80%	1.33	7.53	41.80%	-55.90%	-38.20%
CLDX	CELLDEX THERAPEUTICS INC	$1.38B	-19.80%	-19.00%	-20.97%	-21.90%	0.06	18.92	100.00%	-2,248.80%	-2,248.76%
VKTX	VIKING THERAPEUTICS INC	$3.24B	-14.40%	-14.00%	-15.13%	-15.10%	0.02	44.25	N/A	N/A	N/A
ANVS	ANNOVIS BIO INC	$29.03M	-873.00%	-239.00%	-244.81%	1,333.50%	0.50	3.59	N/A	N/A	N/A
TPST	TEMPEST THERAPEUTICS INC	$323.39M	-245.60%	-103.40%	-148.62%	-244.40%	1.17	2.21	N/A	N/A	N/A
ACHV	ACHIEVE LIFE SCIENCES INC	$90.18M	-110.60%	-72.00%	-117.83%	-129.20%	0.85	5.46	N/A	N/A	N/A
IMVT	IMMUNOVANT INC	$2.74B	-77.90%	-69.80%	-108.38%	1,944.10%	0.19	6.04	N/A	N/A	N/A
ABVX	ABIVAX SA	$451.04M	-149.00%	-66.20%	-143.17%	-301.30%	4.06	1.82	100.00%	-1,415.70%	-1,279.23%
DWTX	DOGWOOD THERAPEUTICS INC	$10.47M	N/A	-49.70%	-13.65%	-366.00%	-2.97	5.21	N/A	N/A	N/A
SNDX	SYNDAX PHARMACEUTICALS INC	$1.22B	-80.70%	-58.70%	-50.51%	-71.50%	1.52	5.82	96.50%	-1,346.10%	-1,325.29%
EYPT	EYEPOINT PHARMACEUTICALS INC	$468.73M	-50.70%	-38.10%	-35.40%	-77.00%	0.24	7.82	91.40%	-302.40%	-302.19%
CABA	CABALETTA BIO INC	$66.98M	-62.00%	-54.70%	-72.88%	-385.60%	0.22	6.15	N/A	N/A	N/A
CDT	CONDUIT PHARMACEUTICALS INC	$3.72M	N/A	-462.10%	248.87%	3,029.00%	-1.62	0.25	N/A	N/A	N/A
LRMR	LARIMAR THERAPEUTICS INC	$169.67M	-52.50%	-46.10%	-64.33%	-59.70%	0.18	7.48	N/A	N/A	N/A
INZY	INOZYME PHARMA INC	$73.88M	-115.30%	-68.10%	-108.04%	-61.90%	1.13	3.56	N/A	N/A	N/A
ETNB	89BIO INC	$1.17B	-81.40%	-70.00%	-81.59%	-101.40%	0.19	13.19	N/A	N/A	N/A
ABOS	ACUMEN PHARMACEUTICALS INC	$68.45M	-45.20%	-37.40%	-46.48%	-41.00%	0.31	6.46	N/A	N/A	N/A
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	$2.69B	-24.30%	-23.00%	-26.56%	-69.40%	0.06	21.11	N/A	N/A	N/A
IMRX	IMMUNEERING CORP	$42.71M	-100.00%	-85.30%	-135.00%	-588.50%	0.27	5.28	N/A	N/A	N/A
RXRX	RECURSION PHARMACEUTICALS INC	$2.25B	-72.90%	-52.90%	-36.86%	-220.30%	0.40	3.81	23.10%	-788.00%	-789.93%
JSPR	JASPER THERAPEUTICS INC	$82.47M	-79.40%	-68.00%	-110.22%	2,901.20%	0.30	4.98	N/A	N/A	N/A
LCTX	LINEAGE CELL THERAPEUTICS INC	$113.95M	-26.10%	-17.70%	-18.75%	2,460.70%	0.46	3.65	96.50%	-195.90%	-195.90%
KZR	KEZAR LIFE SCIENCES INC	$32.00M	-58.70%	-48.70%	-66.06%	-60.30%	0.24	6.76	N/A	N/A	N/A
KRON	KRONOS BIO INC	$54.45M	-75.00%	-55.40%	-78.91%	-91.40%	0.42	7.54	100.00%	-874.10%	-874.08%
VXRT	VAXART INC	$100.30M	-101.80%	-50.00%	-88.32%	-103.50%	1.82	0.75	100.00%	-233.30%	-232.36%
CSCI	COSCIENS BIOPHARMA INC	$10.84M	-84.60%	-38.10%	-54.21%	-162.80%	1.67	3.32	49.30%	-159.70%	-157.46%
KPRX	KIORA PHARMACEUTICALS INC	$9.66M	11.60%	9.10%	18.64%	33.70%	0.42	4.94	100.00%	22.40%	35.46%
JUNS	JUPITER NEUROSCIENCES INC	$21.42M	N/A	-76.80%	-52.26%	158.70%	0.49	2.32	N/A	N/A	N/A
LEXX	LEXARIA BIOSCIENCE CORP	$20.37M	-107.00%	-100.50%	-136.88%	-1,258.20%	0.27	4.24	99.50%	-1,784.20%	-1,784.18%
GDTC	CYTOMED THERAPEUTICS LTD	$27.35M	-24.90%	-22.40%	-26.39%	-62.80%	0.11	9.89	75.40%	-3,621.10%	-3,591.88%
PLUR	PLURI INC	$33.73M	N/A	-55.90%	-78.26%	-37.80%	-4.21	5.04	69.90%	-2,929.20%	-3,049.56%
PMVP	PMV PHARMACEUTICALS INC	$51.41M	-29.30%	-26.40%	-42.28%	-43.40%	0.09	12.22	N/A	N/A	N/A
IVA	INVENTIVA SA	$353.95M	N/A	-195.40%	5,384.47%	-342.30%	-2.12	0.92	100.00%	-1,251.00%	-645.04%
ATHE	ALTERITY THERAPEUTICS LTD	$36.82M	-155.80%	-120.90%	-252.18%	-452.10%	0.36	3.84	100.00%	-531.30%	-530.10%
KAPA	KAIROS PHARMA LTD	$13.54M	-341.00%	-81.50%	-53.77%	-23,888.40%	0.21	4.20	N/A	N/A	N/A
IPHA	INNATE PHARMA SA	$180.75M	-162.90%	-33.50%	-58.27%	-58.30%	11.57	2.60	100.00%	-245.90%	-226.11%
SWTX	SPRINGWORKS THERAPEUTICS INC	$3.47B	-48.30%	-41.80%	-52.97%	-55.80%	0.22	3.81	93.40%	-134.70%	-134.73%
SNSE	SENSEI BIOTHERAPEUTICS INC	$10.16M	-61.90%	-53.60%	-75.33%	-70.20%	0.18	7.70	N/A	N/A	N/A
IOBT	IO BIOTECH INC	$63.90M	-115.30%	-96.10%	-195.07%	2,769.80%	0.44	3.33	N/A	N/A	N/A
INKT	MINK THERAPEUTICS INC	$29.56M	N/A	-142.30%	870.54%	327.20%	-1.29	0.72	N/A	N/A	N/A
SPRC	SCISPARC LTD	$2.97M	79.70%	58.40%	74.02%	127.40%	0.17	5.36	38.70%	481.20%	507.12%
INDP	INDAPTUS THERAPEUTICS INC	$6.64M	-235.90%	-173.40%	-380.80%	1,438.40%	0.86	1.95	N/A	N/A	N/A
INAB	IN8BIO INC	$13.73M	-224.60%	-143.30%	-170.41%	-228.00%	0.45	4.08	N/A	N/A	N/A
IMRN	IMMURON LTD	$10.72M	-52.80%	-45.90%	-70.35%	-285.20%	0.18	6.80	78.60%	-73.90%	-73.82%
XBIO	XENETIC BIOSCIENCES INC	$4.38M	-54.30%	-47.50%	-65.93%	-1,523.70%	0.15	7.37	100.00%	-158.40%	-158.39%
IKNA	IKENA ONCOLOGY INC	$61.29M	-35.30%	-31.70%	-37.54%	-45.10%	0.12	11.80	N/A	N/A	N/A
IGC	IGC PHARMA INC	$24.14M	-122.20%	-88.20%	-137.19%	-207.40%	0.45	1.15	51.50%	-712.70%	-712.70%
CLDI	CALIDI BIOTHERAPEUTICS INC	$13.72M	N/A	-274.70%	-452.33%	-982.10%	7.96	1.08	N/A	N/A	N/A
HOOK	HOOKIPA PHARMA INC	$11.46M	-55.50%	-37.60%	-75.32%	-178.20%	0.61	3.27	100.00%	-99.00%	-99.23%
HEPA	HEPION PHARMACEUTICALS INC	$3.17M	-598.80%	-193.10%	974.70%	-954.80%	-1.87	0.51	N/A	N/A	N/A
GRCE	GRACE THERAPEUTICS INC	$26.47M	-23.30%	-19.80%	-28.56%	1,350.90%	0.17	6.06	N/A	N/A	N/A
GNTA	GENENTA SCIENCE SPA	$71.15M	-54.10%	-48.00%	-70.04%	-71.10%	0.19	6.89	N/A	N/A	N/A
GLYC	GLYCOMIMETICS INC	$16.26M	-230.70%	-177.40%	-712.88%	1,294.20%	1.09	1.92	N/A	N/A	N/A
NBY	NOVABAY PHARMACEUTICALS INC	$3.38M	-7,084.80%	-207.60%	-1,245.34%	-370.00%	-27.54	0.68	66.30%	-88.00%	-73.85%
GLTO	GALECTO INC	$3.70M	-96.90%	-85.50%	-134.28%	-787.30%	0.08	14.07	N/A	N/A	N/A
GNFT	GENFIT SA	$204.73M	2.20%	0.90%	8.68%	15.10%	1.19	1.23	100.00%	2.10%	9.33%
GLMD	GALMED PHARMACEUTICALS LTD	$2.15M	-50.70%	-44.70%	-49.20%	-78.10%	0.13	7.42	N/A	N/A	N/A
ENLV	ENLIVEX THERAPEUTICS LTD	$24.12M	-56.90%	-49.90%	-66.51%	-634.60%	0.17	6.84	N/A	N/A	N/A
SLRX	SALARIUS PHARMACEUTICALS INC	$1.24M	-213.20%	-145.60%	-368.84%	997.50%	1.00	1.98	N/A	N/A	N/A
BLUE	BLUEBIRD BIO INC	$39.94M	-656.30%	-45.80%	-157.14%	-46.70%	-15.60	0.48	-6.60%	-287.20%	-260.20%
MRKR	MARKER THERAPEUTICS INC	$12.74M	-90.40%	-73.10%	-57.56%	-23,349.40%	0.19	6.36	100.00%	-162.80%	-162.06%
SNTI	SENTI BIOSCIENCES INC	$86.33M	-148.80%	-61.30%	-62.33%	-63.70%	1.84	4.49	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: A.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 169.3% over the past year, overperforming other biotech stocks by 246 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 388.6% from Protalix Biotherapeutics's current stock price of $3.07.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 61.89% over the past year, overperforming other biotech stocks by 139 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 61.4% over the past year, overperforming other biotech stocks by 138 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 36.68% from Catalyst Pharmaceuticals's current stock price of $24.29.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.97%, which is 5 percentage points higher than the biotech industry average of 1.92%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.43%, which is 1 percentage points higher than the biotech industry average of 1.92%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.31%, which is -1 percentage points lower than the biotech industry average of 1.92%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.74% in the last day, and up 4.52% over the last week. Regulus Therapeutics was the among the top gainers in the biotechnology industry, gaining 136.8% yesterday.

Regulus Therapeutics shares are trading higher after the company announced it entered into an agreement to be acquired by Novartis AG for $7 in cash per share.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -4.66% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -37.28% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 5.61% in the past year. It has overperformed other stocks in the biotech industry by 82 percentage points.

Are biotech stocks a good buy now?

54.79% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 100.94% over the next year.

1.74% of biotech stocks have a Zen Rating of A (Strong Buy), 4.14% of biotech stocks are rated B (Buy), 42.05% are rated C (Hold), 36.38% are rated D (Sell), and 15.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -162.28x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.